Literature DB >> 28508216

Rescue of Sendai Virus from Cloned cDNA.

Shringkhala Bajimaya1, Tsuyoshi Hayashi1, Toru Takimoto2.   

Abstract

Sendai virus (SeV) is a non-segment negative-sense RNA virus that naturally infects and causes pneumonia in mice. As a prototypic member of the family Paramyxoviridae, SeV has been characterized well, and these studies revealed numerous traits of paramyxovirus biology. The reverse genetics system to rescue SeV was first established in 1995. The virus was rescued from a cloned cDNA that contains full genome sequence flanked by T7 promoter and hepatitis delta virus ribozyme. To rescue SeV, it is necessary to infect cells with a recombinant vaccinia virus vTF7.3 that expresses T7 RNA polymerase, and transfect with the SeV full genome cDNAs together with supporting plasmids encoding NP, P, and L genes under the T7 promoter. Synthesized viral RNA by T7 RNA polymerase will be encapsidated with NP and associated with a polymerase complex composed of P and L. The polymerase complex transcribes and replicates the genome, and produces progeny virions. Rescued SeV needs to be plaque purified to exclude vTF7.3 from viral stock. Reverse genetics system of SeV is relatively efficient compared to other paramyxoviruses, but alternative approaches to rescue poorly growing mutant viruses are also available.

Entities:  

Keywords:  Parainfluenza; Rescue; Sendai virus; Vaccinia virus

Mesh:

Substances:

Year:  2017        PMID: 28508216     DOI: 10.1007/978-1-4939-6964-7_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  Roles of the highly conserved amino acids in the second receptor binding site of the Newcastle disease virus HN protein.

Authors:  Yaqing Liu; Miaomiao Chi; Ying Liu; Hongling Wen; Li Zhao; Yanyan Song; Na Liu; Zhiyu Wang
Journal:  Virol J       Date:  2019-12-27       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.